#VisualAbstract: Addition of argatroban to intravenous alteplase did not improve neurologic outcomes in patients with acute ischemic stroke
Click here to read this study in NEJM
Click here to read this study in NEJM
1. More intensive blood pressure targets were associated with poor functional outcome at 90 days, neurological deterioration, and major disability ...
1. More intensive blood pressure targets were associated with poor functional outcome at 90 days, neurological deterioration, and major disability ...
1. The composite of MRI-detected brain infarcts and symptomatic ischemic stroke was comparable across different doses of asundexian and placebo. ...
1. The CANVAS II randomized controlled trial demonstrated similar functional outcomes between general anesthesia and conscious sedation among patients with ...
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
1. In this randomized clinical trial, among 1893 patients with acute moderate ischemic stroke, significant improvement in neurologic function at ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.